Non-rhabdomyosarcoma Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Non-rhabdomyosarcoma Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) [Phase 1, Phase 2]
This is a clinical trial protocol update for NRSTS2021, a Phase 1/2 study evaluating maintenance pazopanib, limited-margin radiation therapy…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas [Phase 1]
ClinicalTrials.gov entry describing a Phase 1 study of molecular-functional imaging of hypoxia in childhood sarcomas, currently enrolling by…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and preliminary efficacy of combining surufatinib with gemcitabine in pediatric, adolesc…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Indo-cyanine Green (ICG) in Paediatric Oncology MIS [Phase 4]
Phase 4 trial update on using Indo-cyanine Green (ICG) in pediatric oncology, with completed status.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating eribulin mesilate with irinotecan in children with refractory or recurrent solid tumors has completed with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) [Phase 2]
Phase 2 clinical trial update evaluating safety and preliminary activity of eribulin mesylate in pediatric patients with relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating stereotactic body radiotherapy (SBRT) for pulmonary metastases in several pediatric and young adult sarcoma-relat…
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery [Phase 2, Phase 3]
A phase 2/3 trial evaluating radiation therapy with or without combination chemotherapy or pazopanib before surgery in newly diagnosed soft …
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Markers of Anthracycline-Related Cardiac Muscle Injury
The clinical trial NCT01112800 evaluating markers of anthracycline-related cardiac muscle injury in pediatric sarcoma patients has been with…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas [Phase 2]
Phase 2 trial evaluating intensive chemo-radiotherapy with peripheral blood progenitor cell rescue in children with advanced neuroblastoma a…